Cargando…

The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay

BACKGROUND: There is limited information about diabetes and thyroid related autoantibodies in children with type 1 diabetes (T1D) or their siblings in Sri Lanka. OBJECTIVES: To assess in T1D children and their unaffected siblings the prevalence of autoantibodies to (1) glutamic acid decarboxylase (G...

Descripción completa

Detalles Bibliográficos
Autores principales: Atapattu, Navoda, Amoroso, Marie, Powell, Michael, de Silva, D. G. Harendra, de Silva, K. Shamya H., Furmaniak, Jadwiga, Rees Smith, Bernard, Premawardhana, Lakdasa D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939822/
https://www.ncbi.nlm.nih.gov/pubmed/36814577
http://dx.doi.org/10.3389/fendo.2023.1028285
_version_ 1784890945321304064
author Atapattu, Navoda
Amoroso, Marie
Powell, Michael
de Silva, D. G. Harendra
de Silva, K. Shamya H.
Furmaniak, Jadwiga
Rees Smith, Bernard
Premawardhana, Lakdasa D.
author_facet Atapattu, Navoda
Amoroso, Marie
Powell, Michael
de Silva, D. G. Harendra
de Silva, K. Shamya H.
Furmaniak, Jadwiga
Rees Smith, Bernard
Premawardhana, Lakdasa D.
author_sort Atapattu, Navoda
collection PubMed
description BACKGROUND: There is limited information about diabetes and thyroid related autoantibodies in children with type 1 diabetes (T1D) or their siblings in Sri Lanka. OBJECTIVES: To assess in T1D children and their unaffected siblings the prevalence of autoantibodies to (1) glutamic acid decarboxylase (GADA), insulinoma associated antigen-2 (IA-2A) and zinc transporter 8 (ZnT8A) using 3 Screen ICA™ (3-Screen) and individual ELISA assays; (2) insulin (IAA); and (3) thyroid peroxidase (TPOA), thyroglobulin (TgA) and the TSH receptor (TSHRA). METHODS: We selected - (a) consecutive T1D children, and (b) their unaffected siblings of both sexes, from the T1D Registry at Lady Ridgeway Hospital, Colombo. RESULTS: The median age (IQR) of 235 T1D children and 252 unaffected siblings was 11 (8.4, 13.2) and 9 (5.4, 14.9) years respectively, and the duration of T1D was 23 (7, 54) months. (1) T1D children (a) 79.1% were 3-Screen positive; (b) all 3-Screen positives were individual antibody positive (GADA in 74%; IA-2A 31.1%; ZnT8A 38.7%); (c) and were younger (p=0.01 vs 3-Screen negatives); (d) multiple autoantibodies were present in 45.1%; (e) IA-2A (p=0.002) and ZnT8A (p=0.006) prevalence decreased with T1D duration. (f) TPOA and TgA prevalence was higher in T1D children compared to unaffected siblings (28%, p=0.001 and 31%, p=0.004, respectively). (2) Unaffected siblings (a) 6.3% were 3-Screen positive (p=0.001 vs T1D), and 2.4% were positive for IAA; (b) four subjects had two diabetes related autoantibodies, one of whom developed dysglycaemia during follow-up. CONCLUSIONS: The 3-Screen assay, used for the first time in Sri Lankan T1D children and their siblings as a screening tool, shows a high prevalence of T1D related Abs with a high correlation with individual assays, and is also a helpful tool in screening unaffected siblings for future T1D risk. The higher prevalence of thyroid autoantibodies in T1D children is consistent with polyglandular autoimmunity.
format Online
Article
Text
id pubmed-9939822
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99398222023-02-21 The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay Atapattu, Navoda Amoroso, Marie Powell, Michael de Silva, D. G. Harendra de Silva, K. Shamya H. Furmaniak, Jadwiga Rees Smith, Bernard Premawardhana, Lakdasa D. Front Endocrinol (Lausanne) Endocrinology BACKGROUND: There is limited information about diabetes and thyroid related autoantibodies in children with type 1 diabetes (T1D) or their siblings in Sri Lanka. OBJECTIVES: To assess in T1D children and their unaffected siblings the prevalence of autoantibodies to (1) glutamic acid decarboxylase (GADA), insulinoma associated antigen-2 (IA-2A) and zinc transporter 8 (ZnT8A) using 3 Screen ICA™ (3-Screen) and individual ELISA assays; (2) insulin (IAA); and (3) thyroid peroxidase (TPOA), thyroglobulin (TgA) and the TSH receptor (TSHRA). METHODS: We selected - (a) consecutive T1D children, and (b) their unaffected siblings of both sexes, from the T1D Registry at Lady Ridgeway Hospital, Colombo. RESULTS: The median age (IQR) of 235 T1D children and 252 unaffected siblings was 11 (8.4, 13.2) and 9 (5.4, 14.9) years respectively, and the duration of T1D was 23 (7, 54) months. (1) T1D children (a) 79.1% were 3-Screen positive; (b) all 3-Screen positives were individual antibody positive (GADA in 74%; IA-2A 31.1%; ZnT8A 38.7%); (c) and were younger (p=0.01 vs 3-Screen negatives); (d) multiple autoantibodies were present in 45.1%; (e) IA-2A (p=0.002) and ZnT8A (p=0.006) prevalence decreased with T1D duration. (f) TPOA and TgA prevalence was higher in T1D children compared to unaffected siblings (28%, p=0.001 and 31%, p=0.004, respectively). (2) Unaffected siblings (a) 6.3% were 3-Screen positive (p=0.001 vs T1D), and 2.4% were positive for IAA; (b) four subjects had two diabetes related autoantibodies, one of whom developed dysglycaemia during follow-up. CONCLUSIONS: The 3-Screen assay, used for the first time in Sri Lankan T1D children and their siblings as a screening tool, shows a high prevalence of T1D related Abs with a high correlation with individual assays, and is also a helpful tool in screening unaffected siblings for future T1D risk. The higher prevalence of thyroid autoantibodies in T1D children is consistent with polyglandular autoimmunity. Frontiers Media S.A. 2023-02-06 /pmc/articles/PMC9939822/ /pubmed/36814577 http://dx.doi.org/10.3389/fendo.2023.1028285 Text en Copyright © 2023 Atapattu, Amoroso, Powell, de Silva, de Silva, Furmaniak, Rees Smith and Premawardhana https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Atapattu, Navoda
Amoroso, Marie
Powell, Michael
de Silva, D. G. Harendra
de Silva, K. Shamya H.
Furmaniak, Jadwiga
Rees Smith, Bernard
Premawardhana, Lakdasa D.
The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay
title The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay
title_full The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay
title_fullStr The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay
title_full_unstemmed The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay
title_short The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay
title_sort prevalence of diabetes and thyroid related autoantibodies in sri lankan children with type 1 diabetes and their unaffected siblings – the utility of a new screening assay
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939822/
https://www.ncbi.nlm.nih.gov/pubmed/36814577
http://dx.doi.org/10.3389/fendo.2023.1028285
work_keys_str_mv AT atapattunavoda theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay
AT amorosomarie theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay
AT powellmichael theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay
AT desilvadgharendra theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay
AT desilvakshamyah theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay
AT furmaniakjadwiga theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay
AT reessmithbernard theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay
AT premawardhanalakdasad theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay
AT atapattunavoda prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay
AT amorosomarie prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay
AT powellmichael prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay
AT desilvadgharendra prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay
AT desilvakshamyah prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay
AT furmaniakjadwiga prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay
AT reessmithbernard prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay
AT premawardhanalakdasad prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay